142 related articles for article (PubMed ID: 14987000)
21. RA-dimer B, a New Dimeric RA-series Cyclopeptide Incorporating Two Different Types of Cycloisodityrosine Units, from Rubia cordifolia L.
Hitotsuyanagi Y; Tsuchiya T; Ohata M; Yoshida A; Fukaya H; Park HS; Takeya K; Kawahara N
Chem Asian J; 2016 Dec; 11(23):3389-3397. PubMed ID: 27863076
[TBL] [Abstract][Full Text] [Related]
22. Two antitumour bicyclic hexapeptides from Rubia cordifolia.
Takeya K; Yamamiya T; Morita H; Itokawa H
Phytochemistry; 1993 Jun; 33(3):613-5. PubMed ID: 7763798
[TBL] [Abstract][Full Text] [Related]
23. Solid-phase total synthesis of cherimolacyclopeptide E and discovery of more potent analogues by alanine screening.
Shaheen F; Rizvi TS; Musharraf SG; Ganesan A; Xiao K; Townsend JB; Lam KS; Choudhary MI
J Nat Prod; 2012 Nov; 75(11):1882-7. PubMed ID: 23148652
[TBL] [Abstract][Full Text] [Related]
24. Structures and conformations of metabolites of antitumor cyclic hexapeptides, RA-VII and RA-X.
Itokawa H; Saitou K; Morita H; Takeya K; Yamada K
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):2984-9. PubMed ID: 1477912
[TBL] [Abstract][Full Text] [Related]
25. Rubipodanin A, the First Natural N-Desmonomethyl Rubiaceae-Type Cyclopeptide from Rubia podantha, Indicating an Important Role of the N9-Methyl Group in the Conformation and Bioactivity.
Wang Z; Zhao SM; Zhao LM; Chen XQ; Zeng GZ; Tan NH
PLoS One; 2015; 10(12):e0144950. PubMed ID: 26694544
[TBL] [Abstract][Full Text] [Related]
26. Studies on RA derivatives. V. Synthesis and antitumor activity of Ala2-modified RA-VII derivatives.
Itokawa H; Kondo K; Hitotsuyanagi Y; Isomura M; Takeya K
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1402-10. PubMed ID: 8403089
[TBL] [Abstract][Full Text] [Related]
27. 2D- and 3D-QSAR studies on 54 anti-tumor Rubiaceae-type cyclopeptides.
Yan H; Pan X; Tan N; Fan J; Zeng G; Han H
Eur J Med Chem; 2009 Sep; 44(9):3425-32. PubMed ID: 19303172
[TBL] [Abstract][Full Text] [Related]
28. [Cyclopeptides from Rubia schumanniana].
Kuang B; Fan JT; Zhao SM; Tan NH
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2563-70. PubMed ID: 23236752
[TBL] [Abstract][Full Text] [Related]
29. Rubiaceae-Type Cyclopeptides from Galianthe thalictroides.
Figueiredo PO; Matos Mde F; Perdomo RT; Kato WH; Barros MV; Garcez FR; Garcez WS
J Nat Prod; 2016 Apr; 79(4):1165-9. PubMed ID: 26913941
[TBL] [Abstract][Full Text] [Related]
30. Cell growth-inhibitory effects of derivatives of antitumor cyclic hexapeptide RA-V obtained from Rubiae radix (V).
Itokawa H; Takeya K; Mori N; Takanashi M; Yamamoto H; Sonobe T; Kidokoro S
Gan; 1984 Oct; 75(10):929-36. PubMed ID: 6510638
[TBL] [Abstract][Full Text] [Related]
31. Production of monoclonal antibodies against antitumor cyclohexapeptide RA-VII from Rubia cordifolia and their characterization.
Hasuda T; Hitotsuyanagi Y; Takeya K
J Nat Med; 2011 Jul; 65(3-4):588-93. PubMed ID: 21301980
[TBL] [Abstract][Full Text] [Related]
32. New antitumor bicyclic hexapeptides, RA-XI, -XII, -XIII and -XIV from Rubia cordifolia.
Morita H; Yamamiya T; Takeya K; Itokawa H
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1352-4. PubMed ID: 1394660
[TBL] [Abstract][Full Text] [Related]
33. Rubipodanones A-D, naphthohydroquinone dimers from the roots and rhizomes of Rubia podantha.
Wang Z; Zhao SM; Hu YY; Feng L; Zhao LM; Di YT; Tan NH
Phytochemistry; 2018 Jan; 145():153-160. PubMed ID: 29132078
[TBL] [Abstract][Full Text] [Related]
34. Peptide ionophores: synthesis and cation-binding properties of a bicyclic peptide containing glycine and lysine residues.
Crusi E; Giralt E; Andreu D
Pept Res; 1995; 8(2):62-9. PubMed ID: 7655187
[TBL] [Abstract][Full Text] [Related]
35. Biologically active arborinane-type triterpenoids and anthraquinones from Rubia yunnanensis.
Fan JT; Kuang B; Zeng GZ; Zhao SM; Ji CJ; Zhang YM; Tan NH
J Nat Prod; 2011 Oct; 74(10):2069-80. PubMed ID: 21973054
[TBL] [Abstract][Full Text] [Related]
36. Conformational interconversions of the cyclic hexapeptide cyclo(Pro-Gly) 3 .
Deber CM; Torchia DA; Wong SC; Blout ER
Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1825-9. PubMed ID: 4505660
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
[TBL] [Abstract][Full Text] [Related]
38. Preparation and cytotoxicity of cyclic hexapeptides, RA derivatives.
Itokawa H; Kondo K; Hitotsuyanagi Y; Nakamura A; Morita H; Takeya K
Chem Pharm Bull (Tokyo); 1993 Jul; 41(7):1266-9. PubMed ID: 8374996
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of cyclic proline-containing peptides via ring-closing metathesis.
Harris PW; Brimble MA; Gluckman PD
Org Lett; 2003 May; 5(11):1847-50. PubMed ID: 12762668
[TBL] [Abstract][Full Text] [Related]
40. New cytotoxic cyclic peptides and dianthramide from Dianthus superbus.
Hsieh PW; Chang FR; Wu CC; Wu KY; Li CM; Chen SL; Wu YC
J Nat Prod; 2004 Sep; 67(9):1522-7. PubMed ID: 15387653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
